In this issue:
Association between breastfeeding and ovarian cancer risk
Validation of models to diagnose ovarian cancer
Cytoreductive surgery with or without HIPEC for stage III epithelial ovarian cancer
Detection of TP53 clonal variants in Papanicolaou test samples collected up to 6 years prior to high-grade serous epithelial ovarian cancer diagnosis
Apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynaecologic malignant neoplasm
Quality-of-life results for weekly vs 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer
Guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers
Bevacizumab and platinum-based combinations for recurrent ovarian cancer
COVID-19 outcomes of patients with gynaecologic cancer in NY
GNRH agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours
Impact of dose reductions and delays on PFS in ovarian cancer treated with three-weekly or dose-dense carboplatin and paclitaxel regimens
Please login below to download this issue (PDF)